FDA Recall: ED Drug Found in Honey Energy Supplement
The Food and Drug Administration (FDA) has issued a recall for Ashfiat Alharamain Energy Support, a honey energy supplement sold nationwide on Amazon.com and other retail stores. The reason behind the recall is that the product contains an undeclared erectile dysfunction medication called Tadalafil.
Tadalafil is an ingredient in FDA-approved products used to treat male erectile dysfunction, belonging to the phosphodiesterase (PDE5) inhibitor family. However, the FDA has made it clear that products containing this ingredient cannot be marketed as dietary supplements.
Ashfiat Alharamain Energy Support falls into this category due to its undeclared presence of Tadalafil. The product is considered an "unapproved new drug" for which safety and efficacy have not been established by the FDA.
Consumers who have purchased the product are advised to consult a medical professional if they experience any adverse events or side effects related to its use. It's worth noting that the recall was voluntary, and it's unclear how many units of the product were affected.
The FDA is warning consumers to be aware of this potential health risk and to take action to protect themselves. With this recall, it serves as a reminder of the importance of following proper labeling and regulatory guidelines for dietary supplements.
The Food and Drug Administration (FDA) has issued a recall for Ashfiat Alharamain Energy Support, a honey energy supplement sold nationwide on Amazon.com and other retail stores. The reason behind the recall is that the product contains an undeclared erectile dysfunction medication called Tadalafil.
Tadalafil is an ingredient in FDA-approved products used to treat male erectile dysfunction, belonging to the phosphodiesterase (PDE5) inhibitor family. However, the FDA has made it clear that products containing this ingredient cannot be marketed as dietary supplements.
Ashfiat Alharamain Energy Support falls into this category due to its undeclared presence of Tadalafil. The product is considered an "unapproved new drug" for which safety and efficacy have not been established by the FDA.
Consumers who have purchased the product are advised to consult a medical professional if they experience any adverse events or side effects related to its use. It's worth noting that the recall was voluntary, and it's unclear how many units of the product were affected.
The FDA is warning consumers to be aware of this potential health risk and to take action to protect themselves. With this recall, it serves as a reminder of the importance of following proper labeling and regulatory guidelines for dietary supplements.